Analystreport

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target raised by analysts at Royal Bank of Canada from $11.00 to $14.00.

Verrica Pharmaceuticals Inc.  (VRCA) 
Last verrica pharmaceuticals inc. earnings: 3/13 07:00 am Check Earnings Report